{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:57:58Z","timestamp":1761469078999,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Osaka City University Medical Research Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.transci.2020.102969","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:25:32Z","timestamp":1603157132000},"page":"102969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of anti-aquaporin-4 antibody-positive optic neuritis treated by selective immunoadsorption"],"prefix":"10.1016","volume":"60","author":[{"given":"Toshihide","family":"Naganuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ako","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2020.102969_bib0005","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1755-3768.2008.01259.x","article-title":"Anti-aquaporin-4 antibody-positive optic neuritis","volume":"87","author":"Takagi","year":"2009","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.transci.2020.102969_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2020.102969_bib0015","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.transci.2020.102969_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.transci.2020.102969_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: experience with 4857 treatments","volume":"9","author":"Basic-Jukic","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102969_bib0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/1744-9987.12467","article-title":"Removal characteristics of immunoadsorption with the immusorba TR-350 column using conventional and selective plasma separators","volume":"20","author":"Ohkubo","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102969_bib0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102969_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/vox.12191","article-title":"The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange","volume":"108","author":"Koessler","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2020.102969_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1744-9987.12698","article-title":"Immunoadsorption with a tryptophan-immobilized column using conventional and selective plasma separators in the treatment of myasthenia gravis","volume":"22","author":"Ohkubo","year":"2018","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2020.102969_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/1744-9987.12346","article-title":"Removal characteristics of immunoglobulin g subclasses by conventional plasma exchange and selective plasma exchange","volume":"19","author":"Ohkubo","year":"2015","journal-title":"Ther Apher Dial"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220302858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220302858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:17Z","timestamp":1761468797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220302858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1473050220302858"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102969","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of anti-aquaporin-4 antibody-positive optic neuritis treated by selective immunoadsorption","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102969"}}